HIF1A and colitis: Furthermore, prolyl hydroxylases inhibitor, dimethyloxalylglycine (DMOG), induces both HIF-1 and NF-kappaB activity in cultured intestinal epithelial cells, and is strongly reduces epithelial barrier dysfunction in DSS-induced colitis [18].